anthracycline

Type: Keyphrase
Name: anthracycline
First reported 12 mins ago - Updated 12 mins ago - 1 reports

Doxorubicin Attenuates Serotonin-Induced Long-Term Synaptic Facilitation by Phosphorylation of p38 Mitogen-Activated Protein Kinase

* , Yili Zhang * , Brittany L. Coughlin , Leonard J. Cleary , and John H. Byrne Department of Neurobiology and Anatomy, W. M. Keck Center for the Neurobiology of Learning and Memory, University of TexasMedical School at Houston, Houston, Texas 7 ... [Published Journal of Neuroscience - 12 mins ago]
First reported 10 hours ago - Updated 10 hours ago - 1 reports

ESMO 2014: Eisai’s Halaven could provide better quality of life for breast cancer patients

Data posters presented at this year’s European Society for Medical Oncology (ESMO) Congress in Madrid, Spain, provide further evidence on the efficacy and quality of life profile of Halaven (eribulin) in the treatment of patients with locally advanced ... [Published Pharma Letter - 10 hours ago]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Halaven (Eribulin) Provides Clinical Benefit Without an Adverse Effect on Quality of Life: Data Presented at ESMO

/PRNewswire/ --FOR EMEA MEDIA ONLY: NOT FOR SWISS/U.S. JOURNALISTSAdditional Pooled Phase III Data Presented at ESMO Show Significantly Improved Overall Survival for Eribulin Compared to Standard Therapies in Locally Advanced or Metastatic Breast Can ... [Published FinanzNachrichten.de - Sep 26 2014]
First reported Sep 26 2014 - Updated Sep 26 2014 - 1 reports

Guidance to Help Cancer Survivors Avoid Cardiac Death

Oncologists and cardiologists need to work more closely to protect cancer patients from the cardiovascular complications of cancer treatment, according to an expert consensus statement published in the September issue of the Journal of the American Society ... [Published Theheart.org - Sep 26 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Clinigen Confident For Current Year, Raises Dividend As Profit Rises

LONDON ( Alliance News ) - Clinigen Group PLC Wednesday expressed confidence for the current year and raised its total dividend, as it saw profit rise in the year to the end of June.The speciality pharmaceuticals company proposed a total dividend of 3.1 ... [Published HispanicBusiness.com - Sep 24 2014]
First reported Sep 19 2014 - Updated Sep 19 2014 - 1 reports

Exercising during chemotherapy can 'dramatically help shrink tumours', scientists find

Combining exercise with chemotherapy boosts the cancer-fighting effects of the drugs more than the treatment alone.U.S. researchers discovered that mice who exercised while receiving chemotherapy had 'significantly smaller' tumours after two weeks than ... [Published Mail Online UK - Sep 19 2014]
First reported Sep 17 2014 - Updated Sep 18 2014 - 2 reports

CTI BioPharma And Servier Announce Exclusive License And Collaboration Agreement To Develop And Commercialize PIXUVRI®

PIXUVRI is a novel aza-anthracenedione with unique structural and physiochemical properties. PIXUVRI was structurally designed so that it cannot bind iron and perpetuate oxygen radical production or form a long-lived hydroxyl metabolite -- both of which ... [Published Indianapolis Business Journal - Sep 17 2014]
First reported Sep 17 2014 - Updated Sep 17 2014 - 1 reports

New Halaven (Eribulin) and Lenvatinib Data to be Presented at ESMO 2014 Demonstrates Strength of Eisai Oncology Portfolio

/PRNewswire/ --FOR EMEA MEDIA ONLY: NOT FOR SWISS/U.S. JOURNALISTSWealth of data highlights Eisai's commitment to people with cancer and their familiesNine abstracts for Eisai's oncology portfolio are to be presented during the European Society for Medical ... [Published FinanzNachrichten.de - Sep 17 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Methods of treatment using combination therapy

Provided herein are methods of treating a proliferative disease in a subject, comprising administering to the subject a therapeutically effective amount of AC220 and a nucleoside analog, a topoisomerase inhibitor or an anthracycline, or a combination ... [Published Free Patents Online - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 11 2014 - 1 reports

PHILIPS : "Ultrasound Mediated Delivery with Critial-Organ Protection" in Patent Application Approval Process

By a News Reporter-Staff News Editor at Life Science Weekly -- A patent application by the inventors Raju, Balasundar Iyyavu ( Chester, NY ); Hall , Christopher Stephen ( Kirkland, WA ); Seip, Ralf ( Carmel, NY ); Erpelding, Todd Nicholas ( University ... [Published 4 Traders - Sep 11 2014]
First reported Sep 02 2014 - Updated Sep 02 2014 - 1 reports

Crystalline 4′-epidaunorubicin hydrochloride and use thereof

4′-epidaunorubicin hydrochloride is provided in a crystalline form which is stable and readily soluble. A process of producing the crystalline form includes crystallizing 4′-epidaunorubicin hydrochloride in a solvent system including (a) solvent A selected ... [Published Free Patents Online - Sep 02 2014]
Entities: Solvent, Solubility, Alcohol
First reported Aug 25 2014 - Updated Aug 25 2014 - 1 reports

Prevention of Anthracycline-Induced Cardiotoxicity Challenges and Opportunities

Anthracycline compounds are major culprits in chemotherapy-induced cardiotoxicity, which is the chief limiting factor in delivering optimal chemotherapy to cancer patients. Although extensive efforts have been devoted to identifying strategies to prevent ... [Published Journal of the American College of Cardiology - Aug 25 2014]

Quotes

Associate Professor Paul Mainwaring, medical oncologist at The Mater Hospital, Brisbane, said: "New treatment options for Australian women with locally advanced or metastatic breast cancer are welcomed by doctors, patients and their families as there remains a high unmet need for improved therapies. People who have been progressed on previous therapies urgently need new treatments that have demonstrated an overall survival benefit, so the availability of Halaven is very good news."
In a recent report, targeted phage can be used to direct an immune response to a tumor site (Eriksson, et al. 2006 "Tumor specific phage particles promote tumor regression in a mouse melanoma" Cancer Immunol Immunother Pub online September 12)...
Eisai Co Ltd. is a leading global research and development-based pharmaceutical company headquartered in Japan. We define our corporate mission as "giving first thought to patients and their families and to increasing the benefits health care provides" which we call our human healthhealth care (hhc) philosophy...
"Once patients have survived cancer, they don't die from cancer, they die from heart disease. Cardio-oncology is about making sure that doesn't happen" said Juan Carlos Plana, MD, professor of medicine at Baylor College of Medicine in Houston, who was chair of the expert consensus panel

More Content

All (34) | News (33) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Doxorubicin Attenuates Serotonin-Induced Long-T... [Published Journal of Neuroscience - 12 mins ago]
ESMO 2014: Eisai’s Halaven could provide better... [Published Pharma Letter - 10 hours ago]
Liposome composition for targeting egfr receptor [Published PharmCast - Sep 28 2014]
Trastuzumab Trial Shows Fewer Cardiac Problems ... [Published Oncology Times - Sep 27 2014]
Halaven (Eribulin) Provides Clinical Benefit Wi... [Published FinanzNachrichten.de - Sep 26 2014]
Guidance to Help Cancer Survivors Avoid Cardiac... [Published Theheart.org - Sep 26 2014]
Clinigen Confident For Current Year, Raises Div... [Published HispanicBusiness.com - Sep 24 2014]
Mabion Signed An Agreement For The Realization ... [Published BioSpace - Sep 23 2014]
Exercising during chemotherapy can 'dramaticall... [Published Mail Online UK - Sep 19 2014]
CTI BioPharma, Servier team up to develop and c... [Published PharmaBiz - Sep 19 2014]
HER2 in Trastuzumab/Emtansine vs Trastuzumab/Do... [Published General Medicine eJournal - Sep 19 2014]
CTI BioPharma And Servier Announce Exclusive Li... [Published Indianapolis Business Journal - Sep 17 2014]
CTI BioPharma And Servier Announce Exclusive Li... [Published Scottrade - Sep 17 2014]
New Halaven (Eribulin) and Lenvatinib Data to b... [Published FinanzNachrichten.de - Sep 17 2014]
Methods of treatment using combination therapy [Published Free Patents Online - Sep 16 2014]
PHILIPS : "Ultrasound Mediated Delivery with Cr... [Published 4 Traders - Sep 11 2014]
Fertility May Be Preserved With Triptorelin Ad... [Published OncLive - Sep 05 2014]
5E Nausea [Published HighBeam Research - Sep 03 2014]
Crystalline 4′-epidaunorubicin hydrochloride an... [Published Free Patents Online - Sep 02 2014]
Emerging Approaches in Acute Myeloid Leukemia [Published The ASCO Post - Sep 02 2014]
ONLINE FIRST: HERA Trastuzumab Trial Shows Lowe... [Published Oncology Times - Aug 29 2014]
Prevention of Anthracycline-Induced Cardiotoxic... [Published Journal of the American College of Cardiology - Aug 25 2014]
MicroRNA-140-5p as a tumor suppressor and sensi... [Published PharmCast - Jul 18 2014]
Expanded EU approval sets Halaven on course [Published BioPortfolio - Jul 03 2014]
TESARO's (TSRO) CEO Lonnie Moulder on Q1 2014 E... [Published The Street Latest - May 01 2014]
Variants of humanized immunomodulatory monoclon... [Published PharmCast - Apr 15 2014]
Targeting of bone marrow neovasculature [Published PharmCast - Apr 11 2014]
Tumor-initiating cells and methods of use [Published PharmCast - Apr 09 2014]
Gem Pharmaceuticals nabs $4.5 mln [Published PE Hub Blog - Mar 19 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Gem Pharmaceuticals nabs $4.5 mln [Published PE Hub Blog - Mar 19 2014]
Gem Pharmaceuticals said Wednesday that it has received $4.5 million in funding. The investors were current board members Diane Hendricks and Karl Leo. Based in Birmingham, Alabama, Gem Pharmaceuticals is a clinical-stage biopharmaceutical company ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.